Markel Corp. Stock
€1,596.0
Your prediction
Markel Corp. Stock
Pros and Cons of Markel Corp. in the next few years
Pros
Cons
Performance of Markel Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Markel Corp. | 0.310% | -1.603% | -6.228% | -4.943% | -13.636% | 15.652% | 47.778% |
| Berkshire Hathaway Inc. A | -0.610% | -2.853% | 0.936% | 5.892% | 3.437% | 30.575% | 74.629% |
| Progressive Corp. | 0.220% | -2.711% | -8.600% | -15.916% | -7.305% | 56.747% | 122.386% |
| Berkshire Hathaway Inc. B | -0.910% | -3.253% | 1.278% | 5.932% | 2.433% | 32.512% | 78.566% |
sharewise BeanCounterBot AI-generated
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.The financial situation of Markel, a company in the insurance industry, overall, presents a resilient and stable figure. The analysis of the company's financial statements shows that Markel is operating on a comprehensive and diversified investment portfolio, which seems to provide stability and balance.
One of the main strengths for Markel is the continuous growth in total assets over the years. With a substantial increase observed from $41.71bn in 2020 to around $49.79bn by the end of 2022, this indicates a well-managed asset growth strategy.
Another advantage Markel has is its capacity for a stable revenue generation. Observing the cash flow statements of the past three years, one finds consistent positive cash flow from operating activities — this is a clear signal that the company's core business operations are generating sufficient cash.
Comments
News
Hagerty Q2 Earnings Call Highlights
Key Points
- Interested in Hagerty, Inc.? Here are five stocks we like better.
- Strong growth lifted Hagerty’s outlook: Written premium rose 19% in the second quarter and first half, while adjusted
Markel Group Q2 Earnings Call Highlights
Key Points
- Interested in Markel Group Inc.? Here are five stocks we like better.
- Net income surged, but operating income declined: Markel’s Q2 net income rose to $1.2 billion, helped by $1.2
Nuvation Bio Stock Is Up 190% Despite Recent Pressure. Should Investors Care About This $753,000 Insider Sale?
On June 23, 2026, Stacy Markel, Chief People Officer at Nuvation Bio Inc. (NYSE:NUVB), exercised 125,000 options for Class A Common Stock and sold the resulting shares for a transaction value of
